Targeting Inflammation in Atherosclerosis

Targeting inflammation in atherosclerosis is an emerging strategy to treat cardiovascular diseases. Atherosclerosis, the buildup of fatty plaques in arteries, is driven not only by cholesterol but also by chronic inflammation. Inflammatory cells, such as macrophages, infiltrate plaque sites and exacerbate plaque formation, making it unstable and prone to rupture, which can lead to heart attacks or strokes.

Recent research suggests that reducing inflammation could slow or even reverse atherosclerosis. Anti-inflammatory treatments aim to target key inflammatory pathways involved in plaque development. For instance, drugs like canakinumab, which inhibit the interleukin-1β (IL-1β) pathway, have shown promise in reducing inflammation and lowering cardiovascular events. Additionally, statins, commonly used to lower cholesterol, have anti-inflammatory effects that contribute to their cardiovascular benefits.

By focusing on inflammation, researchers are developing new therapies that may complement traditional treatments, providing a more comprehensive approach to preventing and managing atherosclerosis and its associated risks.

    Related Conference of Targeting Inflammation in Atherosclerosis

    July 21-22, 2025

    33rd International Congress on Cardiology and Medical Interventions

    Toronto, Canada
    July 24-25, 2025

    8th International Conference on Cardiovascular Diseases and Therapeutics

    Paris, France
    August 11-12, 2025

    3rd International Conference on World Heart Care

    Toronto, Canada
    August 19-20, 2025

    29th World Cardiology Conference

    Paris, France
    August 21-22, 2025

    34th International Conference on Clinical and Experimental Cardiology Research

    Vancouver, Canada
    August 21-22, 2025

    6th Annual Summit on Cardiology and Heart Diseases

    Rome, Italy
    August 21-22, 2025

    8th Global Cardiovascular Research and Clinical Cardiology

    Vancouver, Canada
    September 08-09, 2025

    39th European Cardiology Conference

    Frankfurt, Germany
    September 22-23, 2025

    14th World Heart Congress

    Dubai, UAE
    September 22-23, 2025

    7th Annual Conference on Vascular Medicine

    Amsterdam, Netherlands
    September 22-23, 2025

    4th Global Summit on Cardiology and Cardiac Surgery

    Tokyo, Japan
    September 25-26, 2025

    13th International Conference on Hypertension and Healthcare

    Zurich, Switzerland
    October 13-14, 2025

    14th International Conference on Cardiology and Cardiovascular Medicine Research

    Vienna, Austria
    October 20-21, 2025

    39th World Congress on Heart Diseases

    Frankfurt, Germany
    October 20-21, 2025

    36th International Conference on Cardiology and Heart Failure

    Osaka, Japan
    October 22-23, 2025

    12th International Conference on Geriatric Cardiology, Cardiovascular Diseases and Palliative Care

    Paris, France
    November 03-04, 2025

    12th International Conference on Hypertension and Cardiovascular Diseases

    Rome, Italy
    November 13-14, 2025

    6th Global Summit on Heart Congress

    Paris, France
    November 18-19, 2025

    26th International Conference on New Horizons in Cardiology and Cardiologists Education

    Paris, France
    November 19-20, 2025

    7th World Heart Congress

    Tokyo, Japan
    November 24-25, 2025

    36th Annual Cardiologists Conference

    Barcelona, Spain
    November 27-28, 2025

    32nd World Heartcare Summit

    Aix-en-Provence, France
    January 12-13, 2026

    12th International Heart Conference

    Dubai, UAE
    March 18-19, 2026

    15th World Heart Congress

    Paris, France
    March 26-27, 2026

    13th International Conference on Interventional Cardiology

    London,
    May 27-28, 2026

    6th World Congress on Congestive Heart Failure & Angina

    Paris, France

    Targeting Inflammation in Atherosclerosis Conference Speakers

      Recommended Sessions

      Related Journals

      Are you interested in